Cargando…
Erythropoietin in Glaucoma: From Mechanism to Therapy
Glaucoma can cause irreversible vision loss and is the second leading cause of blindness worldwide. The disease mechanism is complex and various factors have been implicated in its pathogenesis, including ischemia, excessive oxidative stress, neurotropic factor deprivation, and neuron excitotoxicity...
Autores principales: | Lai, Yi-Fen, Lin, Ting-Yi, Chen, Yi-Hao, Lu, Da-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917746/ https://www.ncbi.nlm.nih.gov/pubmed/36769310 http://dx.doi.org/10.3390/ijms24032985 |
Ejemplares similares
-
The Latest Evidence of Erythropoietin in the Treatment of Glaucoma
por: Lin, Ting-Yi, et al.
Publicado: (2022) -
Erythropoietin in Optic Neuropathies: Current Future Strategies for Optic Nerve Protection and Repair
por: Lai, Yi-Fen, et al.
Publicado: (2022) -
Erythropoietin levels in aqueous humor of patients with glaucoma
por: Nassiri, Nader, et al.
Publicado: (2012) -
Astrocyte polarization in glaucoma: a new opportunity
por: Liu, Yi-Xin, et al.
Publicado: (2022) -
Outcomes of Small Size Ahmed Glaucoma Valve Implantation in Asian Chronic Angle-Closure Glaucoma
por: Huang, Ke-Hao, et al.
Publicado: (2021)